The global vascular access devices market size was valued at around USD 4.3 billion in 2021 and is projected to reach at around USD 7.2 billion by 2030, expanding at a CAGR of 5.9% during the forecast period, 2022–2030. The growth of the market is attributed to growing use of vascular access devices in pediatric patients and increasing number of chemotherapy procedures.
Vascular access devices are used to deliver certain medicines and solutions safely and directly to bloodstream and used for diagnostic reasons such as administration of medication, total parental nutrition, blood transfusion, and central venous pressure readings. Medicines are delivered into the large vein to enable fast delivery and to avoid damage. Vascular access devices are helpful for delivering fluid nutritional components. Vascular access devices are used for patients that require long-term treatments, such as chemotherapy. These devices are usually made of silicon and latex among other substances. These devices are inserted into veins through peripheral vessels.
The COVID-19 negatively affected the medical devices market, due to significant dip in device sales caused by the pandemic. However, supply of equipment for the management of the pandemic such as ventilators, personal protective equipment, and general hospital supplies registered a surge in sales. Many hospitals and surgical centers canceled and postponed elective surgeries such as cardiovascular surgeries.
The report on the global vascular access devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Vascular Access Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019–2020 |
Forecast Period |
2022–2030 |
Segmentation |
Applications (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals), and Types (PICC Catheters, Implantable Port, Dialysis Catheters, and CVC Catheters) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Boston Scientific Corporation; Cook Medical; Fresenius Kabi AG; Smiths Medical; |
On the basis of applications, the vascular access devices market is segmented into ambulatory surgical centers, specialty clinics, and hospitals. The hospitals segment is projected to expand at a considerable CAGR during the forecast period, due to the increasing number of chemotherapy procedures and rising use of vascular access devices in pediatric patients. The specialty clinics segment is anticipated to account for a major market share during the forecast period, as specialty clinics aid in providing nutritional support and drawing blood samples.
Based on types, the market is divided into PICC catheters, implantable port, dialysis catheters, and CVC catheters. The dialysis catheters segment is expected to hold a significant share of the market in the coming years, due to rising cases of blood transfusion. The CVC catheters segment accounts for a significant market share, due to rising demand for central venous access among patients during long periods of intravenous therapy such as chemotherapy.
In terms of regions, the vascular access devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period, owing to increasing number of clinical trials and growing research for vascular access devices in the region. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to increasing prevalence of life-style related disorders in the region.
Key players competing in the global vascular access devices market are Boston Scientific Corporation; Cook Medical; Fresenius Kabi AG; Smiths Medical; Vygon; Becton, Dickinson; Argon Medical Devices; B. Braun Melsungen; Kimal Healthcare; Comed; Medtronic; Angio Dynamics; BD; and Teleflex Incorporated.
Product launches and organic growth strategies, such as participation in events, are being prioritized by a number of companies. These companies also adopt acquisitions and collaborations to boost their market share.
Key players competing in the global vascular access devices market are Boston Scientific Corporation; Cook Medical; Fresenius Kabi AG; Smiths Medical; Vygon; Becton, Dickinson; Argon Medical Devices; B. Braun Melsungen; Kimal Healthcare; Comed; Medtronic; Angio Dynamics; BD; and Teleflex Incorporated.
Product launches and organic growth strategies, such as participation in events, are being prioritized by a number of companies. These companies also adopt acquisitions and collaborations to boost their market share.
Some frequently asked quetions about this report!
The global vascular access devices market size was valued at USD 4.3 billion in 2021.
Rising demand for central venous access among patients during long periods of intravenous therapy is expected to drive the market.
The global vascular access devices market is anticipated to expand at a CAGR of 5.9% during the forecast period, 2022–2030.
North America is expected to constitute a key share of the market during the forecast period.
Key players competing in the global vascular access devices market are Boston Scientific Corporation; Cook Medical; Fresenius Kabi AG; Smiths Medical; Vygon; Becton, Dickinson; Argon Medical Devices; B. Braun Melsungen; Kimal Healthcare; Comed; Medtronic; Angio Dynamics; BD; and Teleflex Incorporated.
Some other reports from this category!